FDA adds new warning on GLP-1 drugs for rare eye condition

The U.S. Food and Drug Administration announced Monday that it is requiring new warnings on popular diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a potential increased risk for a rare eye condition that can cause permanent vision loss.

ABC News' Dr. Darien Sutton has the latest.